A Randomized, Two-Treatments, Two-Periods, Crossover, Open label, Laboratory-Blind, Single Dose Bioequivalence Study between Vildagliptin/Metformin 50 mg/1000 mg Film Coated Tablets (Sensityn®) and Galvusmet® 50 mg/1000 mg Film Coated Tablets in healthy adults under fed conditions
By: J. Shiekmydeen, T. Siddiqi, K. Chakraborty, S. Khalaf, M. Albarazi, I. Eqtefan and J. Sliva
Authors
J. Shiekmydeen
Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia
T. Siddiqi
Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia
K. Chakraborty
Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia
S. Khalaf
Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia
M. Albarazi
Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia
I. Eqtefan
Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia
DOI: https://doi.org/10.2478/afpuc-2023-0019 | Journal eISSN: 2453-6725
Language: English
Page range: 1 - 9
Submitted on: Aug 16, 2023
Accepted on: Aug 30, 2023
Published on: Oct 20, 2023
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2023 J. Shiekmydeen, T. Siddiqi, K. Chakraborty, S. Khalaf, M. Albarazi, I. Eqtefan, J. Sliva, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.